To characterize a novel survival pathway that regulates the resistance of pancreatic cancer cells to TRAIL, we performed high-throughput screening using a library of 1,280 biologically active compounds (LOPAC-1280TM). Here, TNFSF10 is linked to familial pancreatic carcinoma.